{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:42:07Z","timestamp":1791495727143,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Occup Med Toxicol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>4,4'-Diaminodiphenylsulphone (Dapsone) is widely used for a variety of infectious, immune and hypersensitivity disorders, with indications ranging from Hansen's disease, inflammatory disease and insect bites, all of which may be seen as manifestations in certain occupational diseases. However, the use of dapsone may be associated with a plethora of adverse effects, some of which may involve the pulmonary parenchyma. Methemoglobinemia with resultant cyanosis, bone marrow aplasia and\/or hemolytic anemia, peripheral neuropathy and the potentially fatal dapsone hypersensitivity syndrome <jats:bold>(DHS)<\/jats:bold>, the focus of this review, may all occur individually or in combination. <jats:bold>DHS<\/jats:bold> typically presents with a triad of fever, skin eruption, and internal organ (lung, liver, neurological and other systems) involvement, occurring several weeks to as late as 6 months after the initial administration of the drug. In this sense, it may resemble a <jats:bold>DRESS syndrome<\/jats:bold> (Drug Rash with Eosinophilia and Systemic Symptoms). <jats:bold>DHS<\/jats:bold> must be promptly identified, as untreated, the disorder could be fatal. Moreover, the pulmonary\/systemic manifestations may be mistaken for other disorders. Eosinophilic infiltrates, pneumonitis, pleural effusions and interstitial lung disease may be seen. This syndrome is best approached with the immediate discontinuation of the offending drug and prompt administration of oral or intravenous glucocorticoids. An immunological-inflammatory basis of the syndrome can be envisaged, based on the pathological picture and excellent response to antiinflammatory therapy. Since dapsone is used for various indications, physicians from all specialties may encounter <jats:bold>DHS<\/jats:bold> and need to familiarize themselves with the salient features about the syndrome and its management.<\/jats:p>","DOI":"10.1186\/1745-6673-1-9","type":"journal-article","created":{"date-parts":[[2006,6,6]],"date-time":"2006-06-06T18:30:08Z","timestamp":1149618608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The Dapsone Hypersensitivity Syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations"],"prefix":"10.1186","volume":"1","author":[{"given":"Semaan G","family":"Kosseifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvana","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima N","family":"Nassour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guha","family":"Krishnaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,6,6]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"YI Zhu","year":"2001","unstructured":"Zhu YI, Stiller MJ: Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 2001, 45: 420\u2013434. 10.1067\/mjd.2001.114733","journal-title":"J Am Acad Dermatol"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.mcna.2005.07.001","volume":"89","author":"EM Singletary","year":"2005","unstructured":"Singletary EM, Rochman AS, Bodmer JC, Holstege CP: Envenomations\n1. Med Clin North Am 2005, 89: 1195\u20131224. 10.1016\/j.mcna.2005.07.001","journal-title":"Med Clin North Am"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1046\/j.1365-2230.2003.01336.x","volume":"28","author":"KS Leslie","year":"2003","unstructured":"Leslie KS, Gaffney K, Ross CN, Ridley S, Barker TH, Garioch JJ: A near fatal case of the dapsone hypersensitivity syndrome in a patient with urticarial vasculitis. Clin Exp Dermatol 2003, 28: 496\u2013498. 10.1046\/j.1365-2230.2003.01336.x","journal-title":"Clin Exp Dermatol"},{"key":"9_CR4","first-page":"171","volume":"67","author":"K Pavithran","year":"1999","unstructured":"Pavithran K, Bindu V: Dapsone syndrome: hepatitis-B infection a risk factor for its development? Int J Lepr Other Mycobact Dis 1999, 67: 171\u2013172.","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/CRIAI:24:3:229","volume":"24","author":"SR Knowles","year":"2003","unstructured":"Knowles SR, Shapiro LE, Shear NH: Reactive metabolites and adverse drug reactions: clinical considerations. Clin Rev Allergy Immunol 2003, 24: 229\u2013238. 10.1385\/CRIAI:24:3:229","journal-title":"Clin Rev Allergy Immunol"},{"key":"9_CR6","first-page":"57","volume":"72","author":"PN Rao","year":"2001","unstructured":"Rao PN, Lakshmi TS: Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. Lepr Rev 2001, 72: 57\u201362.","journal-title":"Lepr Rev"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/000155599750010012","volume":"79","author":"J Christiansen","year":"1999","unstructured":"Christiansen J, Tegner E, Irestedt M: Dapsone hypersensitivity syndrome in a patient with cutaneous lupus erythematosus. Acta Derm Venereol 1999, 79: 482. 10.1080\/000155599750010012","journal-title":"Acta Derm Venereol"},{"key":"9_CR8","first-page":"266","volume":"95","author":"PA Reeve","year":"1992","unstructured":"Reeve PA, Ala J, Hall JJ: Dapsone syndrome in Vanuatu: a high incidence during multidrug treatment (MDT) of leprosy. J Trop Med Hyg 1992, 95: 266\u2013270.","journal-title":"J Trop Med Hyg"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230X-3-21","volume":"3","author":"S Itha","year":"2003","unstructured":"Itha S, Kumar A, Dhingra S, Choudhuri G: Dapsone induced cholangitis as a part of dapsone syndrome: a case report. BMC Gastroenterol 2003, 3: 21. 10.1186\/1471-230X-3-21","journal-title":"BMC Gastroenterol"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccm.2004.05.006","volume":"25","author":"P Camus","year":"2004","unstructured":"Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P: Drug-induced and iatrogenic infiltrative lung disease\n8. Clin Chest Med 2004, 25: 479\u2013519, vi. 10.1016\/j.ccm.2004.05.006","journal-title":"Clin Chest Med"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1378\/chest.103.1.305","volume":"103","author":"S Begbie","year":"1993","unstructured":"Begbie S, Burgess KR: Maloprim-induced pulmonary eosinophilia. Chest 1993, 103: 305\u2013306.","journal-title":"Chest"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S0140-6736(94)92066-4","volume":"343","author":"M Janier","year":"1994","unstructured":"Janier M, Guillevin L, Badillet G: Pulmonary eosinophilia associated with dapsone. Lancet 1994, 343: 860\u2013861. 10.1016\/S0140-6736(94)92066-4","journal-title":"Lancet"},{"key":"9_CR13","first-page":"3","volume":"11","author":"S Arunthathi","year":"1998","unstructured":"Arunthathi S, Raju S: Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report. Acta Leprol 1998, 11: 3\u20135.","journal-title":"Acta Leprol"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/bmj.317.7152.181","volume":"317","author":"D Jaffuel","year":"1998","unstructured":"Jaffuel D, Lebel B, Hillaire-Buys D, Pene J, Godard P, Michel FB, Blayac JP, Bousquet J, Demolyi P: Eosinophilic pneumonia induced by dapsone. BMJ 1998, 317: 181.","journal-title":"BMJ"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.297.6658.1240","volume":"297","author":"AC Davidson","year":"1988","unstructured":"Davidson AC, Bateman C, Shovlin C, Marrinan M, Burton GH, Cameron IR: Pulmonary toxicity of malaria prophylaxis. BMJ 1988, 297: 1240\u20131241.","journal-title":"BMJ"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/00000441-200403000-00010","volume":"327","author":"MJ Tobin-D'Angelo","year":"2004","unstructured":"Tobin-D'Angelo MJ, Hoteit MA, Brown KV, Ray SM, King MD: Dapsone-induced hypersensitivity pneumonitis mimicking Pneumocystis carinii pneumonia in a patient with AIDS. Am J Med Sci 2004, 327: 163\u2013165. 10.1097\/00000441-200403000-00010","journal-title":"Am J Med Sci"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00005176-199801000-00017","volume":"26","author":"CC Corp","year":"1998","unstructured":"Corp CC, Ghishan FK: The sulfone syndrome complicated by pancreatitis and pleural effusion in an adolescent receiving dapsone for treatment of acne vulgaris. J Pediatr Gastroenterol Nutr 1998, 26: 103\u2013105. 10.1097\/00005176-199801000-00017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"9_CR18","first-page":"447","volume":"130","author":"L Mery","year":"2003","unstructured":"Mery L, Dega H, Prost C, Dubertret L: [Dapsone-induced sensory peripheral neuropathy]. Ann Dermatol Venereol 2003, 130: 447\u2013449.","journal-title":"Ann Dermatol Venereol"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0190-9622(83)80147-9","volume":"9","author":"JD Fine","year":"1983","unstructured":"Fine JD, Katz SI, Donahue MJ, Hendricks AA: Psychiatric reaction to dapsone and sulfapyridine\n1. J Am Acad Dermatol 1983, 9: 274\u2013275.","journal-title":"J Am Acad Dermatol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bmj.1.6105.78","volume":"1","author":"BI Hoffbrand","year":"1978","unstructured":"Hoffbrand BI: Dapsone and renal papillary necrosis\n1. Br Med J 1978, 1: 78.","journal-title":"Br Med J"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.iac.2004.03.003","volume":"24","author":"GW Volcheck","year":"2004","unstructured":"Volcheck GW: Clinical evaluation and management of drug hypersensitivity\n5. Immunol Allergy Clin North Am 2004, 24: 357\u201371, v. 10.1016\/j.iac.2004.03.003","journal-title":"Immunol Allergy Clin North Am"},{"key":"9_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.iac.2004.03.007","volume":"24","author":"JK McKenna","year":"2004","unstructured":"McKenna JK, Leiferman KM: Dermatologic drug reactions\n2. Immunol Allergy Clin North Am 2004, 24: 399\u2013423, vi. 10.1016\/j.iac.2004.03.007","journal-title":"Immunol Allergy Clin North Am"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-2133.1997.tb03814.x","volume":"137","author":"KE McKenna","year":"1997","unstructured":"McKenna KE, Robinson J: The dapsone hypersensitivity syndrome occurring in a patient with dermatitis herpetiformis. Br J Dermatol 1997, 137: 657\u2013658. 10.1111\/j.1365-2133.1997.tb03814.x","journal-title":"Br J Dermatol"},{"key":"9_CR24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0190-9622(96)90667-2","volume":"35","author":"R Prussick","year":"1996","unstructured":"Prussick R, Shear NH: Dapsone hypersensitivity syndrome. J Am Acad Dermatol 1996, 35: 346\u2013349. 10.1016\/S0190-9622(96)90667-2","journal-title":"J Am Acad Dermatol"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3810\/hp.2001.08.245","volume":"36","author":"G Krishnaswamy","year":"2001","unstructured":"Krishnaswamy G: Treatment strategies for bronchial asthma: an update\n33. Hosp Pract (Off Ed) 2001, 36: 25\u201335.","journal-title":"Hosp Pract (Off Ed)"},{"key":"9_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/107999004323065057","volume":"24","author":"B Shakoory","year":"2004","unstructured":"Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G: The role of human mast cell-derived cytokines in eosinophil biology\n14. J Interferon Cytokine Res 2004, 24: 271\u2013281. 10.1089\/107999004323065057","journal-title":"J Interferon Cytokine Res"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - New mechanisms for old drugs\n1. New England Journal of Medicine 2005, 353: 1711\u20131723. 10.1056\/NEJMra050541","journal-title":"New England Journal of Medicine"},{"key":"9_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/107999003321455453","volume":"23","author":"SM Fitzgerald","year":"2003","unstructured":"Fitzgerald SM, Chi DS, Hall HK, Reynolds SA, Aramide O, Lee SA, Krishnaswamy G: GM-CSF induction in human lung fibroblasts by IL-1beta, TNF-alpha, and macrophage contact\n24. J Interferon Cytokine Res 2003, 23: 57\u201365. 10.1089\/107999003321455453","journal-title":"J Interferon Cytokine Res"},{"key":"9_CR29","first-page":"85","volume":"19","author":"A Chogle","year":"2000","unstructured":"Chogle A, Nagral A, Soni A, Agale S, Jamadar Z: Dapsone hypersensitivity syndrome with coexisting acute hepatitis E. Indian J Gastroenterol 2000, 19: 85\u201386.","journal-title":"Indian J Gastroenterol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/clpt.1992.8","volume":"51","author":"A Gupta","year":"1992","unstructured":"Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, Shear NH, Cannon M, Spielberg SP: Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides\n1. Clin Pharmacol Ther 1992, 51: 56\u201367.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Occupational Medicine and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6673-1-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:39:01Z","timestamp":1630453141000},"score":1,"resource":{"primary":{"URL":"https:\/\/occup-med.biomedcentral.com\/articles\/10.1186\/1745-6673-1-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1186\/1745-6673-1-9","relation":{},"ISSN":["1745-6673"],"issn-type":[{"value":"1745-6673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,6]]},"assertion":[{"value":"6 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}